474 results on '"van Heyningen, Veronica"'
Search Results
202. Genetics in Clinical Oncology. Edited by R. S. K Chaganti and J. L. German. Oxford University Press. 1985280 pages £35.00. ISBN 0 19 503609 3
- Author
-
van Heyningen, Veronica, primary
- Published
- 1986
- Full Text
- View/download PDF
203. Enzyme-linked immunospecific assays for human alphafetoprotein using monoclonal antibodies
- Author
-
Brock, David J.H., primary, Barron, Lilias, additional, and van Heyningen, Veronica, additional
- Published
- 1982
- Full Text
- View/download PDF
204. The facts on cystic fibrosis testing
- Author
-
BROCK, DAVID J.H., primary and VAN HEYNINGEN, VERONICA, additional
- Published
- 1986
- Full Text
- View/download PDF
205. Human-mouse hybrids carrying fragments of single human chromosomes selected by tumor growth
- Author
-
Porteous, David J., primary, Wilkinson, Maureen M., additional, Fletcher, Judy M., additional, and van Heyningen, Veronica, additional
- Published
- 1989
- Full Text
- View/download PDF
206. Monoclonal antibodies to cystic fibrosis antigen
- Author
-
Hayward, Caroline, primary, Chung, Susan, additional, Brock, David J.H., additional, and Van Heyningen, Veronica, additional
- Published
- 1986
- Full Text
- View/download PDF
207. Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11
- Author
-
Spurr, Nigel K., primary, Gough, Alan C., additional, Gosden, John, additional, Rout, Derek, additional, Porteous, David J., additional, van Heyningen, Veronica, additional, and Docherty, Andrew J.P., additional
- Published
- 1988
- Full Text
- View/download PDF
208. Corrigendum: SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome
- Author
-
Shaw, Natalie D, Brand, Harrison, Kupchinsky, Zachary A, Bengani, Hemant, Plummer, Lacey, Jones, Takako I, Erdin, Serkan, Williamson, Kathleen A, Rainger, Joe, Stortchevoi, Alexei, Samocha, Kaitlin, Currall, Benjamin B, Dunican, Donncha S, Collins, Ryan L, Willer, Jason R, Lek, Angela, Lek, Monkol, Nassan, Malik, Pereira, Shahrin, Kammin, Tammy, Lucente, Diane, Silva, Alexandra, Seabra, Catarina M, Chiang, Colby, An, Yu, Ansari, Morad, Rainger, Jacqueline K, Joss, Shelagh, Smith, Jill Clayton, Lippincott, Margaret F, Singh, Sylvia S, Patel, Nirav, Jing, Jenny W, Law, Jennifer R, Ferraro, Nalton, Verloes, Alain, Rauch, Anita, Steindl, Katharina, Zweier, Markus, Scheer, Ianina, Sato, Daisuke, Okamoto, Nobuhiko, Jacobsen, Christina, Tryggestad, Jeanie, Chernausek, Steven, Schimmenti, Lisa A, Brasseur, Benjamin, Cesaretti, Claudia, García-Ortiz, Jose E, Buitrago, Tatiana Pineda, Silva, Orlando Perez, Hoffman, Jodi D, Mühlbauer, Wolfgang, Ruprecht, Klaus W, Loeys, Bart L, Shino, Masato, Kaindl, Angela M, Cho, Chie-Hee, Morton, Cynthia C, Meehan, Richard R, van Heyningen, Veronica, Liao, Eric C, Balasubramanian, Ravikumar, Hall, Janet E, Seminara, Stephanie B, Macarthur, Daniel, Moore, Steven A, Yoshiura, Koh-ichiro, Gusella, James F, Marsh, Joseph A, Graham, John M, Lin, Angela E, Katsanis, Nicholas, Jones, Peter L, Crowley, William F, Davis, Erica E, FitzPatrick, David R, and Talkowski, Michael E
- Published
- 2017
- Full Text
- View/download PDF
209. Cystic fibrosis: In search of the gene.
- Author
-
van Heyningen, Veronica
- Published
- 1984
- Full Text
- View/download PDF
210. Clinical utility gene card for: Aniridia
- Author
-
Richardson, Rose, Hingorani, Melanie, Van Heyningen, Veronica, Gregory-Evans, Cheryl, and Moosajee, Mariya
- Published
- 2016
- Full Text
- View/download PDF
211. Clinical utility gene card for: WAGR syndrome.
- Author
-
Clericuzio, Carol, Hingorani, Melanie, Crolla, John A., van Heyningen, Veronica, and Verloes, Alain
- Subjects
SYNDROMES ,GENEALOGY ,DISEASES ,GENETICS ,GENES ,WAGR syndrome - Abstract
The article presents a clinical utility gene card for WAGR syndrome. It is stated that the breakpoints of the syndrome differ in individual cases, but the minimum deletion involves both PAX6 and WT1. As stated, the clinical sensitivity can be dependent on variable factors such as age or family history.
- Published
- 2011
- Full Text
- View/download PDF
212. Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis.
- Author
-
Yu Chen, Doughman, Yong-Qiu, Gu, Shi, Jarrell, Andrew, Aota, Shin-Ichi, Cvekl, Ales, Watanabe, Michiko, Dunwoodie, Sally L., Johnson, Randall S., van Heyningen, Veronica, Kleinjan, Dirk A., Beebe, David C., and Yu-Chung Yang
- Subjects
EYE diseases ,BLOOD vessels ,MORPHOGENESIS ,ETIOLOGY of diseases ,GENOTYPE-environment interaction ,EMBRYOLOGY - Abstract
Cited2 is a transcriptional modulator with pivotal roles in different biological processes. Cited2-deficient mouse embryos manifested two major defects in the developing eye. An abnormal corneal-lenticular stalk was characteristic of Cited2-/- developing eyes, a feature reminiscent of Peters' anomaly, which can be rescued by increased Pax6 gene dosage in Cited2-/- embryonic eyes. In addition, the hyaloid vascular system showed hyaloid hypercellularity consisting of aberrant vasculature, which might be correlated with increased VEGF expression in the lens. Deletion of Hif1a (which encodes HIF-1) in Cited2-/- lens specifically eliminated the excessive accumulation of cellular mass and aberrant vasculature in the developing vitreous without affecting the corneal-lenticular stalk phenotype. These in vivo data demonstrate for the first time dual functions for Cited2: one upstream of, or together with, Pax6 in lens morphogenesis; and another in the normal formation of the hyaloid vasculature through its negative modulation of HIF-1 signaling. Taken together, our study provides novel mechanistic revelation for lens morphogenesis and hyaloid vasculature formation and hence might offer new insights into the etiology of Peters' anomaly and ocular hypervascularity. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
213. Controlled overexpression of Pax6 in vivo negatively autoregulates the Pax6 locus, causing cell-autonomous defects of late cortical progenitor proliferation with little effect on cortical arealization.
- Author
-
Manuel, Martine, Georgala, Petrina A., Carr, Catherine B., Chanas, Simon, Kleinjan, Dirk A., Martynoga, Ben, Mason, John O., Molinek, Michael, Pinson, Jeni, Pratt, Thomas, Quinn, Jane C., Simpson, T. Ian, Tyas, David A., Van Heyningen, Veronica, West, John D., and Price, David J.
- Subjects
TRANSCRIPTION factors ,PROTEINS ,GENE expression ,GENETIC regulation ,TRANSGENIC mice - Abstract
Levels of expression of the transcription factor Pax6 vary throughout corticogenesis in a rostro-lateral
high to caudo-mediallow gradient across the cortical proliferative zone. Previous loss-of-function studies have indicated that Pax6 is required for normal cortical progenitor proliferation, neuronal differentiation, cortical lamination and cortical arealization, but whether and how its level of expression affects its function is unclear. We studied the developing cortex of PAX77 YAC transgenic mice carrying several copies of the human PAX6 locus with its full complement of regulatory regions. We found that PAX77 embryos express Pax6 in a normal spatial pattern, with levels up to three times higher than wild type. By crossing PAX77 mice with a new YAC transgenic line that reports Pax6 expression (DTy54), we showed that increased expression is limited by negative autoregulation. Increased expression reduces proliferation of late cortical progenitors specifically, and analysis of PAX77 ↔wild-type chimeras indicates that the defect is cell autonomous. We analyzed cortical arealization in PAX77 mice and found that, whereas the loss of Pax6 shifts caudal cortical areas rostrally, Pax6 overexpression at levels predicted to shift rostral areas caudally has very little effect. These findings indicate that Pax6 levels are stabilized by autoregulation, that the proliferation of cortical progenitors is sensitive to altered Pax6 levels and that cortical arealization is not. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
214. Mutations in SOX2 cause anophthalmia–esophageal–genital (AEG) syndrome.
- Author
-
Williamson, Kathleen A., Hever, Ann M., Rainger, Joe, Rogers, R. Curtis, Magee, Alex, Fiedler, Zdenek, Keng, Wee Teik, Sharkey, Freddie H., McGill, Niolette, Hill, Clare J., Schneider, Adele, Messina, Mario, Turnpenny, Peter D., Fantes, Judy A., van Heyningen, Veronica, and FitzPatrick, David R.
- Published
- 2006
- Full Text
- View/download PDF
215. Mechanisms of non-Mendelian inheritance in genetic disease.
- Author
-
van Heyningen, Veronica and Yeyati, Patricia L.
- Published
- 2004
- Full Text
- View/download PDF
216. Gene games of the future.
- Author
-
Van Heyningen, Veronica
- Subjects
- ENGINEERING the Human Germline (Book)
- Abstract
Reviews the book 'Engineering the Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children,' edited by Gregory Stock and John Campbell.
- Published
- 2000
- Full Text
- View/download PDF
217. Aniridia.
- Author
-
Hingorani, Melanie, Hanson, Isabel, and van Heyningen, Veronica
- Subjects
- *
ANIRIDIA , *EYE abnormalities , *DELETION mutation , *IRIS (Eye) diseases , *PHENOTYPES , *THERAPEUTICS - Abstract
Aniridia is a rare congenital disorder in which there is a variable degree of hypoplasia or the absence of iris tissue associated with multiple other ocular changes, some present from birth and some arising progressively over time. Most cases are associated with dominantly inherited mutations or deletions of the PAX6 gene. This article will review the clinical manifestations, the molecular basis including genotype-phenotype correlations, diagnostic approaches and management of aniridia. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
218. DNaseI Hypersensitivity and Ultraconservation Reveal Novel, Interdependent Long-Range Enhancers at the Complex Pax6 Cis-Regulatory Region.
- Author
-
McBride, David J., Buckle, Adam, van Heyningen, Veronica, and Kleinjan, Dirk A.
- Subjects
- *
GENES , *LOCUS (Genetics) , *TRANSGENIC mice , *VISUAL perception , *GENE mapping , *GENETIC techniques - Abstract
The PAX6 gene plays a crucial role in development of the eye, brain, olfactory system and endocrine pancreas. Consistent with its pleiotropic role the gene exhibits a complex developmental expression pattern which is subject to strict spatial, temporal and quantitative regulation. Control of expression depends on a large array of cis-elements residing in an extended genomic domain around the coding region of the gene. The minimal essential region required for proper regulation of this complex locus has been defined through analysis of human aniridia-associated breakpoints and YAC transgenic rescue studies of the mouse smalleye mutant. We have carried out a systematic DNase I hypersensitive site (HS) analysis across 200 kb of this critical region of mouse chromosome 2E3 to identify putative regulatory elements. Mapping the identified HSs onto a percent identity plot (PIP) shows many HSs correspond to recognisable genomic features such as evolutionarily conserved sequences, CpG islands and retrotransposon derived repeats. We then focussed on a region previously shown to contain essential long range cis-regulatory information, the Pax6 downstream regulatory region (DRR), allowing comparison of mouse HS data with previous human HS data for this region. Reporter transgenic mice for two of the HS sites, HS5 and HS6, show that they function as tissue specific regulatory elements. In addition we have characterised enhancer activity of an ultra-conserved cis-regulatory region located near Pax6, termed E60. All three cis-elements exhibit multiple spatio-temporal activities in the embryo that overlap between themselves and other elements in the locus. Using a deletion set of YAC reporter transgenic mice we demonstrate functional interdependence of the elements. Finally, we use the HS6 enhancer as a marker for the migration of precerebellar neuro-epithelium cells to the hindbrain precerebellar nuclei along the posterior and anterior extramural streams allowing visualisation of migratory defects in both pathways in Pax6Sey/Sey mice. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
219. Regulatory architecture of the Pax6 locus
- Author
-
Buckle, Adam James, Van Heyningen, Veronica, and Gilbert, Nick
- Subjects
572.8 ,Pax6 ,gene regulation ,chromatin - Abstract
Pax6 is a highly conserved developmental regulator with a complex temporal, spatial and quantitative expression pattern, that is crucial for correct development of the central nervous system, the eye, and pancreas. Accordingly, the Pax6 gene resides in a complex genomic locus containing a large array of long-range tissue-specific cis-regulatory elements primarily identified through multispecies sequence conservation and reporter studies. I have set out to understand how the chromatin architecture of the locus contributes to the mechanism and specificity of cis-regulatory interactions. As well as addressing whether the DNA looping model for regulatory interactions applies to the mouse Pax6 locus, I will identify which elements facilitate such interactions and if they vary between cell types. Utilising ChIP-array technology the distribution and variability of key regulatory histone modifications and factors were assessed in a set of Pax6 expressing and non-expressing mouse cell lines, acting as models for different regulatory states of the locus. Work in other loci suggests a key role for CTCF and cohesin (subunit Rad21) in chromatin organisation and long distance regulatory interactions. ChIP-chip for CTCF/Rad21 across the Pax6 locus identified numerous sites within the gene and at distal regulatory locations. The majority of these sites are cell type invariable. The active enhancer modification H3K27ac identified both known and several novel putative enhancer elements distributed through the locus that are highly cell type specific. A subset of CTCF/Rad21 sites also acquire the active enhancer modification H3K27ac in a cell type dependent manor, suggesting that CTCF/Rad21 may facilitate looping to the target gene from these sites. Using reporter based assays, putative regulatory elements marked by the looping factors and active histone modifications showed a diverse range of functional activities. Unexpectedly only 3 of the 7 CTCF sites tested showed classical insulator activity in an enhancer blocking reporter assay. Surprisingly the strongest insulator tested resided within intron 7 the Pax6 gene. Other CTCF/Rad21 sites were neutral or enhancers in the insulator assay. This reveals the disparity between predicting regulatory properties using ChIP binding profiles alone and the actual outcome of functional reporter experiments. A novel element, CTCF6 showed a ChIP signature of CTCF/Rad21/H3K27ac in all Pax6 expressing tissues, and functioned as a strong enhancer in transient transfection and stable LacZ reporter assays. CTCF6 recapitulated a broad range of Pax6 expression patterns, at multiple embryonic stages, including the brain, neural tube and pancreas. A second novel element, E-120 identified in the pancreatic derived cell line, drove stable embryonic reporter expression in the embryonic pancreas and sub set of brain regions. Together this has expanded the repertoire and size of Pax6’s regulatory landscape particular in the upstream region. Chromatin conformation capture (3C) was used to characterise the dynamic chromatin architecture of the locus and identify the interaction profiles from three CTCF/Rad21 binding regulatory locations within the Pax6 locus. This revealed a core set of regulatory interactions with the Pax6 gene, while individual elements showed a more variable set of cell type specific interactions. The CTCF6 enhancer showed highly cell type specific promoter interactions throughout the Pax6 gene, indicative of enhancer-promoter looping not detected in the non-expressing cells. While the downstream site CTCF5 at the edge of a cluster of regulatory elements known as the DRR (differentially regulated region), interacted with both the gene and an upstream element CTCF7 300 kb away only in the Pax6 expressing locus. Together these results reveal Pax6 has a chromatin hub structure with regulatory loops from upstream and downstream bringing distant yet variable active elements in to the vicinity of the Pax6 promoters where they can act. This work has revealed new roles for CTCF/cohesin sites in transcriptional regulation of Pax6 and how the cis-regulatory activity and structure of the locus varies across different cell types.
- Published
- 2014
220. Role of DNA supercoiling in genome structure and regulation
- Author
-
Corless, Samuel, Van Heyningen, Veronica, and Gilbert, Nicholas
- Subjects
572 ,DNA supercoiling ,RNA transcription ,topoisomerase enzymes ,topoisomerase I ,topoisomerase II ,CpG island - Abstract
A principle challenge of modern biology is to understand how the human genome is organised and regulated within a nucleus. The field of chromatin biology has made significant progress in characterising how protein and DNA modifications reflect transcription and replication state. Recently our lab has shown that the human genome is organised into large domains of altered DNA helical twist, called DNA supercoiling domains, similar to the regulatory domains observed in prokaryotes. In my PhD I have analysed how the maintenance and distribution of DNA supercoiling relates to biological function in human cells. DNA supercoiling domains are set up and maintained by the balanced activity of RNA transcription and topoisomerase enzymes. RNA polymerase twists the DNA, over-winding in front of the polymerase and under-winding behind. In contrast topoisomerases relieve supercoiling from the genome by introducing transient nicks (topoisomerase I) or double strand breaks (topoisomerase II) into the double helix. Topoisomerase activity is critical for cell viability, but the distribution of topoisomerase I, IIα and IIβ in the human genome is not known. Using a chromatin immunoprecipitation (ChIP) approach I have shown that topoisomerases are enriched in large chromosomal domains, with distinct topoisomerase I and topoisomerase II domains. Topoisomerase I is correlated with RNA polymerase II, genes and underwound DNA, whereas topoisomerase IIα and IIβ are associated with each other and over-wound DNA. This indicates that different topoisomerase proteins operate in distinct regions of the genome and can be independently regulated depending on the genomic environment. Transcriptional regulation by DNA supercoiling is believed to occur through changes in gene promoter structure. To investigate DNA supercoiling my lab has developed biotinylated trimethylpsoralen (bTMP) as a DNA structure probe, which preferentially intercalates into under-wound DNA. Using bTMP in conjunction with microarrays my lab identified a transcription and topoisomerase dependent peak of under-wound DNA in a meta-analysis of several hundred genes (Naughton et al. (2013)). In a similar analysis, Kouzine et al. (2013) identified an under-wound promoter structure and proposed a model of topoisomerase distribution for the regulation of promoter DNA supercoiling. To better understand the role of supercoiling and topoisomerases at gene promoters, a much larger-scale analysis of these factors was required. I have analysed the distribution of bTMP at promoters genome wide, confirming a transcription and expression dependent distribution of DNA supercoils. DNA supercoiling is distinct at CpG island and non-CpG island promoters, and I present a model in which over-wound DNA limits transcription from both CpG island promoters and repressed genes. In addition, I have mapped by ChIP topoisomerase I and IIβ at gene promoters on chromosome 11 and identified a different distribution to that proposed by Kouzine et al. (2013), with topoisomerase I maintaining DNA supercoiling at highly expressed genes. This study provides the first comprehensive analysis of DNA supercoiling at promoters and identifies the relationship between supercoiling, topoisomerase distribution and gene expression. In addition to regulating transcription, DNA supercoiling and topoisomerases are important for genome stability. Several studies have suggested a link between DNA supercoiling and instability at common fragile sites (CFSs), which are normal structures in the genome that frequently break under replication stress and cancer. bTMP was used to measure DNA supercoiling across FRA3B and FRA16D CFSs, identifying a transition to a more over-wound DNA structure under conditions that induce chromosome fragility at these regions. Furthermore, topoisomerase I, IIα and IIβ showed a pronounced depletion in the vicinity of the FRA3B and FRA16D CFSs. This provides the first experimental evidence of a role for DNA supercoiling in fragile site formation.
- Published
- 2014
221. Identification and functional modelling of plausibly causative cis-regulatory variants in a highly-selected cohort with X-linked intellectual disability.
- Author
-
Bengani, Hemant, Grozeva, Detelina, Moyon, Lambert, Bhatia, Shipra, Louros, Susana R., Hope, Jilly, Jackson, Adam, Prendergast, James G., Owen, Liusaidh J., Naville, Magali, Rainger, Jacqueline, Grimes, Graeme, Halachev, Mihail, Murphy, Laura C., Spasic-Boskovic, Olivera, van Heyningen, Veronica, Kind, Peter, Abbott, Catherine M., Osterweil, Emily, and Raymond, F. Lucy
- Subjects
- *
INTELLECTUAL disabilities , *LABORATORY mice , *X chromosome , *EXOMES , *PHENOTYPES , *NUCLEOTIDE sequencing , *OLFACTORY receptors - Abstract
Identifying causative variants in cis-regulatory elements (CRE) in neurodevelopmental disorders has proven challenging. We have used in vivo functional analyses to categorize rigorously filtered CRE variants in a clinical cohort that is plausibly enriched for causative CRE mutations: 48 unrelated males with a family history consistent with X-linked intellectual disability (XLID) in whom no detectable cause could be identified in the coding regions of the X chromosome (chrX). Targeted sequencing of all chrX CRE identified six rare variants in five affected individuals that altered conserved bases in CRE targeting known XLID genes and segregated appropriately in families. Two of these variants, FMR1CRE and TENM1CRE, showed consistent site- and stage-specific differences of enhancer function in the developing zebrafish brain using dual-color fluorescent reporter assay. Mouse models were created for both variants. In male mice Fmr1CRE induced alterations in neurodevelopmental Fmr1 expression, olfactory behavior and neurophysiological indicators of FMRP function. The absence of another likely causative variant on whole genome sequencing further supported FMR1CRE as the likely basis of the XLID in this family. Tenm1CRE mice showed no phenotypic anomalies. Following the release of gnomAD 2.1, reanalysis showed that TENM1CRE exceeded the maximum plausible population frequency of a XLID causative allele. Assigning causative status to any ultra-rare CRE variant remains problematic and requires disease-relevant in vivo functional data from multiple sources. The sequential and bespoke nature of such analyses renders them time-consuming and challenging to scale for routine clinical use. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
222. Investigating the genetic and molecular basis of age-related macular degeneration
- Author
-
Stanton, Chloe May, Van Heyningen, Veronica, and Wright, Alan
- Subjects
617.7 ,Age-related macular degeneration ,AMD ,HTRA1 - Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness worldwide, affecting an estimated 50 million individuals aged over 65 years. Environmental and genetic risk-factors contribute to the development of AMD. An AMD-risk locus on chromosome 10q26 spans two genes, ARMS2 and HTRA1, and controversy exists as to which variants are responsible for increased risk of disease. Recent work suggests that HTRA1 expression levels are significantly increased in carriers of the risk haplotype associated with AMD. However, relatively little is known about the interactions, substrate specificity and roles in disease played by this secreted serine protease. This thesis aims to elucidate the potential role played by HTRA1 in AMD pathogenesis. A combination of tandem affinity purification (TAP) and yeast two-hybrid techniques was used to identify interacting partners of HTRA1. A number of proteins, with diverse roles in the alternative complement pathway, cell signaling, cell-matrix interactions, inflammation, angiogenesis and fibrosis, were identified. These are attractive candidates for further study as such processes are disturbed in AMD, implicating HTRA1 and its binding partners in disease development. One interacting partner, Complement Factor D (CFD), is a key activator in the alternative complement pathway. CFD, a 24 kDa serine protease, is expressed as an inactive zymogen, from which a signal peptide and activation peptide are cleaved before release of the mature, active protein into the circulation. In vitro studies show that CFD interacts with, and can be a substrate for, HTRA1. The interacting domain between the two proteins is localised to a region of 30 amino acids at the N-terminal end of proCFD. The 5 amino acid pro-peptide of CFD appears to be both necessary and sufficient for proteolysis of CFD by HTRA1. Investigation of the functional relevance of the interaction between HTRA1 and CFD shows that proCFD is cleaved by HTRA1, whilst mature CFD is not subjected to proteolysis. HTRA1-mediated cleavage of CFD forms an active protease, leading to activation of factor B in the alternative complement pathway in in vitro assays. Furthermore, a normal complement response is restored to CFD-depleted serum by addition of proCFD activated by HTRA1. Thus, an HTRA1- mediated increase in alternative complement pathway activity may explain a proportion of the AMD-risk attributed to the chr10q26 locus. Genetic and protein-based approaches were used to study the potential role of CFD in AMD pathogenesis, independent of an interaction with HTRA1. An intronic SNP, rs3826945, was significantly associated with increased risk of AMD in two British case-control cohorts, and in a combined meta-analysis with 4 additional cohorts from North America and Europe (p-value = 0.032, Odds Ratio = 1.112 in 4765 cases and 2693 controls). Assessment of copy number variation and sequencing of CFD did not identify any functional variants which may explain the association with disease. However, plasma levels of CFD were measured by ELISA in 751 AMD cases and 474 controls, and were found to be significantly elevated in AMD cases compared to controls (p-value = 0.00025). This further implicates complement activation in AMD pathogenesis, and makes CFD an attractive candidate for therapeutic intervention. An alteration in the level of activated CFD, possibly mediated via an interaction with HTRA1, either at the systemic or local tissue level, may play a role in disease development and progression.
- Published
- 2012
223. Epigenetic regulation of germline-specific genes
- Author
-
Hackett, Jamie Alexander, Meehan, Richard., and Van Heyningen, Veronica
- Subjects
572.8 ,epigenetics ,DNA methylation ,Kaiso ,germline ,Tex19 - Abstract
In mammals, epigenetic modifications and trans-acting effectors coordinate gene expression during development and impose transcriptional memories that define specific cell lineages and cell-types. Methylation at CpG dinucleotides is an epigenetic mechanism through which transcriptional silencing is established and heritably maintained through development. Functionally, DNA methylation regulates key biological processes such as X-chromosome inactivation, transposon repression and genomic imprinting. However, the extent to which DNA methylation is the primary regulator of single-copy gene expression and the precise mechanism of methylation-dependent silencing remain undetermined. Here, I identify a novel set of germline-specific candidate genes putatively regulated by DNA methylation. Analysis of one candidate gene, Tex19, demonstrates that promoter CpG methylation is the primary and exclusive mechanism for regulating developmental silencing in somatic lineages. Genetic or pharmacological removal of CpG methylation triggers robust de-repression of Tex19 and loss of transcriptional memory. Moreover, Tex19 critically relies on de novo methylation, mediated by Dnmt3b, to impose silencing in differentiating ES cells and somatic cells in vivo from embryonic day (E)7.5. Reporter gene and ChIP analysis demonstrate that Tex19 is strongly activated by general transcription factors and is not marked by repressive histone modifications in somatic lineages, consistent with differential DNA methylation per se being the primary mechanism of regulating expression. Full transcriptional silencing of Tex19 is critically dependent on the methyl-binding protein (MBP) Kaiso, which is only recruited to methylated Tex19 promoter. The reliance on DNA methylation and Kaiso for silencing in somatic cells establishes an epigenetic memory responsible for maintaining expression in germline and pluripotent cell types through successive developmental cycles. This thesis represents the first causal report of lineagespecific promoter DNA methylation directing silencing of an in vivo gene through recruitment of an MBP.
- Published
- 2010
224. Investigating a C1QTNF5 mutation associated with macular degeneration
- Author
-
Slingsby, Fern, Wright, Alan., and Van Heyningen, Veronica
- Subjects
617.7 ,late-onset retinal macular degeneration ,age-related macular degeneration ,regulatory proteins ,complement factor H - Abstract
C1QTNF5 is a 25kDa short chain collagen of unknown function which is mutated in late-onset retinal macular degeneration (L-ORMD). L-ORMD is an autosomal dominant disease characterised by sub-retinal pigment epithelial deposits leading to photoreceptor death and visual loss and shows several similarities to age-related macular degeneration (AMD). A Tyr402His polymorphism in complement factor H (CFH), a regulatory protein in the innate immune system, has been associated with increased risk of AMD. C1QTNF5 and CFH are both expressed and secreted by the retinal pigment epithelium (RPE) which supports photoreceptors and is responsible for phagocytosis of shed rod photoreceptor outer segments (ROS). The properties of the normal C1QTNF5 and disease-associated Ser163Arg mutation were examined in detail, including protein characterisation, cellular processing and function. Recombinant wild type and mutant C1QTNF5 were produced and their multimerisation and solubility functions compared. Both proteins were found to be soluble and to form similar multimeric species which were resistant to reducing conditions, as seen in other short chain collagens. Due to the similarities between LORMD and AMD, a proposed interaction between C1QTNF5 and CFH was investigated. CFH is composed of 20 short consensus repeats (SCR) and interactions were confirmed between C1QTNF5 and both CFH and SCR modules 7-8 and 19-20. CFH showed a greater affinity for mutant C1QTNF5 compared with wild type on the basis of surface plasmon resonance assays. Stably transfected RPE-derived cell lines were created which expressed either wild type or mutant C1QTNF5. Both proteins were found to be secreted and showed similar cellular processing with no evidence of aggregation or retention of the mutant protein within the endoplasmic reticulum. In order to investigate C1QTNF5 function, phagocytosis of ROS by the stably transfected cell lines was carried out. Cells expressing wild type C1QTNF5 showed greater ROS phagocytosis compared with mutant C1QTNF5-expressing or untransfected cells. Addition of anti-C1QTNF5 antibody increased ROS phagocytosis further. In summary, it is proposed that wild type and mutant C1QTNF5 are secreted by the RPE where they interact with CFH. C1QTNF5 is also shown to have a role in ROS phagocytosis, with mutation in C1QTNF5 affecting phagocytosis efficiency, which may contribute to sub-RPE deposit formation. The results suggest that CFH may also be involved in this process, suggesting a common pathogenic pathway between L-ORMD and AMD.
- Published
- 2009
225. Genome-wide linkage and haplotype sharing analysis implicates the MCDR3 locus as a candidate region for a developmental macular disorder in association with digit abnormalities.
- Author
-
Cipriani, Valentina, Kalhoro, Ambreen, Arno, Gavin, Silva, Raquel S., Pontikos, Nikolas, Puech, Virginie, McClements, Michelle E., Hunt, David M., van Heyningen, Veronica, Michaelides, Michel, Webster, Andrew R., Moore, Anthony T., and Puech, Bernard
- Subjects
- *
HAPLOTYPES , *RETINAL degeneration , *VISION disorders in children , *EYE development , *NUCLEOTIDE sequencing - Abstract
Background: Developmental macular disorders are a heterogeneous group of rare retinal conditions that can cause significant visual impairment from childhood. Among these disorders, autosomal dominant North Carolina macular dystrophy (NCMD) has been mapped to 6q16 (MCDR1) with recent support for a non-coding disease mechanism ofPRDM13. A second locus on 5p15-5p13 (MCDR3) has been implicated in a similar phenotype, but the disease-causing mechanism still remains unknown. Methods: Two families affected by a dominant developmental macular disorder that closely resembles NCMD in association with digit abnormalities were included in the study. Family members with available DNA were genotyped using the Affymetrix GeneChip Human Mapping 250K Sty array. A parametric multipoint linkage analysis assuming a fully penetrant dominant model was performed using MERLIN. Haplotype sharing analysis was carried out using the non-parametric Homozygosity Haplotype method. Whole-exome sequencing was conducted on selected affected individuals. Results: Linkage analysis excludedMCDR1from the candidate regions (LOD < –2). There was suggestive linkage (LOD = 2.7) at two loci, including 9p24.1 and 5p15.32 that overlapped withMCDR3. The haplotype sharing analysis in one of the families revealed a 5 cM shared IBD segment at 5p15.32 (pvalue = 0.004). Whole-exome sequencing did not provide conclusive evidence for disease-causing alleles. Conclusions: These findings do not exclude that this phenotype may be allelic with NCMDMCDR3at 5p15 and leave the possibility of a non-coding disease mechanism, in keeping with recent findings on 6q16. Further studies, including whole-genome sequencing, may help elucidate the underlying genetic cause of this phenotype and shed light on macular development and function. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
226. Look Back to the Future. The Celis of the Body: A History ofSomatic Celi Genetics.
- Author
-
VAN HEYNINGEN, VERONICA
- Published
- 1996
227. KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability.
- Author
-
Yeyati, Patricia L., Schiller, Rachel, Mali, Girish, Kasioulis, Ioannis, Kawamura, Akane, Adams, Ian R., Playfoot, Christopher, Gilbert, Nick, van Heyningen, Veronica, Wills, Jimi, von Kriegsheim, Alex, Finch, Andrew, Sakai, Juro, Schofield, Christopher J., Jackson, Ian J., and Mill, Pleasantine
- Subjects
- *
CILIA & ciliary motion , *ACTIN , *CELLS - Abstract
Cilia assembly and disassembly are coupled to actin dynamics, ensuring a coherent cellular response during environmental change. How these processes are integrated remains undefined. The histone lysine demethylase KDM3A plays important roles in organismal homeostasis. Loss-of-function mouse models of Kdm3a phenocopy features associated with human ciliopathies, whereas human somatic mutations correlate with poor cancer prognosis. We demonstrate that absence of KDM3A facilitates ciliogenesis, but these resulting cilia have an abnormally wide range of axonemal lengths, delaying disassembly and accumulating intraflagellar transport (IFT) proteins. KDM3A plays a dual role by regulating actin gene expression and binding to the actin cytoskeleton, creating a responsive "actin gate" that involves ARP2/3 activity and IFT. Promoting actin filament formation rescues KDM3A mutant ciliary defects. Conversely, the simultaneous depolymerization of actin networks and IFT overexpression mimics the abnormal ciliary traits of KDM3A mutants. KDM3A is thus a negative regulator of ciliogenesis required for the controlled recruitment of IFT proteins into cilia through the modulation of actin dynamics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
228. Functional Assessment of Disease-Associated Regulatory Variants In Vivo Using a Versatile Dual Colour Transgenesis Strategy in Zebrafish.
- Author
-
Bhatia, Shipra, Gordon, Christopher T., Foster, Robert G., Melin, Lucie, Abadie, Véronique, Baujat, Geneviève, Vazquez, Marie-Paule, Amiel, Jeanne, Lyonnet, Stanislas, van Heyningen, Veronica, and Kleinjan, Dirk A.
- Subjects
- *
GENETIC regulation , *BIOLOGICAL variation , *GENETICS of disease susceptibility , *TRANSCRIPTION factors , *ZEBRA danio - Abstract
Disruption of gene regulation by sequence variation in non-coding regions of the genome is now recognised as a significant cause of human disease and disease susceptibility. Sequence variants in cis-regulatory elements (CREs), the primary determinants of spatio-temporal gene regulation, can alter transcription factor binding sites. While technological advances have led to easy identification of disease-associated CRE variants, robust methods for discerning functional CRE variants from background variation are lacking. Here we describe an efficient dual-colour reporter transgenesis approach in zebrafish, simultaneously allowing detailed in vivo comparison of spatio-temporal differences in regulatory activity between putative CRE variants and assessment of altered transcription factor binding potential of the variant. We validate the method on known disease-associated elements regulating SHH, PAX6 and IRF6 and subsequently characterise novel, ultra-long-range SOX9 enhancers implicated in the craniofacial abnormality Pierre Robin Sequence. The method provides a highly cost-effective, fast and robust approach for simultaneously unravelling in a single assay whether, where and when in embryonic development a disease-associated CRE-variant is affecting its regulatory function. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
229. Identification and functional modelling of plausibly causative cis-regulatory variants in a highly-selected cohort with X-linked intellectual disability
- Author
-
Catherine M. Abbott, Mihail Halachev, Detelina Grozeva, Hugues Roest Crollius, F. Lucy Raymond, James Prendergast, Peter C. Kind, Hemant Bengani, Jacqueline K. Rainger, Laura C. Murphy, Liusaidh J Owen, Veronica van Heyningen, Adam Jackson, Lambert Moyon, Graeme R. Grimes, Olivera Spasic-Boskovic, Magali Naville, Emily K. Osterweil, Jilly Hope, David R. FitzPatrick, Shipra Bhatia, Susana R. Louros, MRC Institute of Genetics and Molecular Medicine [Edinburgh] (IGMM), University of Edinburgh-Medical Research Council, Institut de biologie de l'ENS Paris (IBENS), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Département de Biologie - ENS Paris, École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Edinburgh, University of Cambridge [UK] (CAM), Cardiff University, Cambridge University Hospitals NHS Foundation Trust, Institut de biologie de l'ENS Paris (UMR 8197/1024) (IBENS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Département de Biologie - ENS Paris, Département de Biologie - ENS Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Grozeva, Detelina [0000-0003-3239-8415], Moyon, Lambert [0000-0003-2390-3942], Bhatia, Shipra [0000-0002-2091-7858], Louros, Susana R. [0000-0002-1012-0386], Jackson, Adam [0000-0002-3554-6682], Prendergast, James G. [0000-0001-8916-018X], Owen, Liusaidh J. [0000-0003-0363-1775], Naville, Magali [0000-0002-6821-2427], Grimes, Graeme [0000-0002-3106-5996], Halachev, Mihail [0000-0002-4594-4588], Murphy, Laura C. [0000-0003-0029-0434], Spasic-Boskovic, Olivera [0000-0003-1583-8132], van Heyningen, Veronica [0000-0003-0359-0141], Abbott, Catherine M. [0000-0001-8794-7173], Osterweil, Emily [0000-0003-0582-2284], FitzPatrick, David R. [0000-0003-4861-969X], Apollo - University of Cambridge Repository, Louros, Susana R [0000-0002-1012-0386], Prendergast, James G [0000-0001-8916-018X], Owen, Liusaidh J [0000-0003-0363-1775], Murphy, Laura C [0000-0003-0029-0434], Abbott, Catherine M [0000-0001-8794-7173], and FitzPatrick, David R [0000-0003-4861-969X]
- Subjects
Male ,Embryology ,Embryo, Nonmammalian ,X-linked intellectual disability ,medicine.disease_cause ,Hippocampus ,Midbrain ,Animals, Genetically Modified ,Cohort Studies ,Fragile X Mental Retardation Protein ,Mice ,0302 clinical medicine ,Gene Frequency ,Genes, X-Linked ,Medicine and Health Sciences ,Exome ,Regulatory Elements, Transcriptional ,Zebrafish ,X chromosome ,Genetics ,0303 health sciences ,education.field_of_study ,Mutation ,Mammalian Genomics ,Multidisciplinary ,Eukaryota ,Brain ,Chromosome Mapping ,Tenascin ,Animal Models ,Genomics ,Pedigree ,Phenotype ,Experimental Organism Systems ,Osteichthyes ,Vertebrates ,Medicine ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Anatomy ,Brainstem ,Research Article ,Genotype ,Science ,Population ,Mouse Models ,Nerve Tissue Proteins ,Biology ,Research and Analysis Methods ,03 medical and health sciences ,Model Organisms ,medicine ,Animals ,Humans ,Allele ,education ,Gene ,Alleles ,030304 developmental biology ,Whole genome sequencing ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,Genome, Human ,Embryos ,Organisms ,Biology and Life Sciences ,medicine.disease ,FMR1 ,Disease Models, Animal ,Fish ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,Animal Genomics ,Genetic Loci ,Animal Studies ,Mental Retardation, X-Linked ,Zoology ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
Funder: BBSRC studentship, Identifying causative variants in cis-regulatory elements (CRE) in neurodevelopmental disorders has proven challenging. We have used in vivo functional analyses to categorize rigorously filtered CRE variants in a clinical cohort that is plausibly enriched for causative CRE mutations: 48 unrelated males with a family history consistent with X-linked intellectual disability (XLID) in whom no detectable cause could be identified in the coding regions of the X chromosome (chrX). Targeted sequencing of all chrX CRE identified six rare variants in five affected individuals that altered conserved bases in CRE targeting known XLID genes and segregated appropriately in families. Two of these variants, FMR1CRE and TENM1CRE, showed consistent site- and stage-specific differences of enhancer function in the developing zebrafish brain using dual-color fluorescent reporter assay. Mouse models were created for both variants. In male mice Fmr1CRE induced alterations in neurodevelopmental Fmr1 expression, olfactory behavior and neurophysiological indicators of FMRP function. The absence of another likely causative variant on whole genome sequencing further supported FMR1CRE as the likely basis of the XLID in this family. Tenm1CRE mice showed no phenotypic anomalies. Following the release of gnomAD 2.1, reanalysis showed that TENM1CRE exceeded the maximum plausible population frequency of a XLID causative allele. Assigning causative status to any ultra-rare CRE variant remains problematic and requires disease-relevant in vivo functional data from multiple sources. The sequential and bespoke nature of such analyses renders them time-consuming and challenging to scale for routine clinical use.
- Published
- 2021
230. A survey of ancient conserved non-coding elements in the PAX6 locus reveals a landscape of interdigitated cis-regulatory archipelagos.
- Author
-
Bhatia, Shipra, Monahan, Jack, Ravi, Vydianathan, Gautier, Philippe, Murdoch, Emma, Brenner, Sydney, van Heyningen, Veronica, Venkatesh, Byrappa, and Kleinjan, Dirk A.
- Subjects
- *
NON-coding DNA , *ARCHIPELAGOES , *GENE expression , *CELL growth , *CELL determination , *GENETIC disorders , *DISEASE susceptibility - Abstract
Abstract: Biological differences between cell types and developmental processes are characterised by differences in gene expression profiles. Gene-distal enhancers are key components of the regulatory networks that specify the tissue-specific expression patterns driving embryonic development and cell fate decisions, and variations in their sequences are a major contributor to genetic disease and disease susceptibility. Despite advances in the methods for discovery of putative cis-regulatory sequences, characterisation of their spatio-temporal enhancer activities in a mammalian model system remains a major bottle-neck. We employed a strategy that combines gnathostome sequence conservation with transgenic mouse and zebrafish reporter assays to survey the genomic locus of the developmental control gene PAX6 for the presence of novel cis-regulatory elements. Sequence comparison between human and the cartilaginous elephant shark (Callorhinchus milii) revealed several ancient gnathostome conserved non-coding elements (agCNEs) dispersed widely throughout the PAX6 locus, extending the range of the known PAX6 cis-regulatory landscape to contain the full upstream PAX6-RCN1 intergenic region. Our data indicates that ancient conserved regulatory sequences can be tested effectively in transgenic zebrafish even when not conserved in zebrafish themselves. The strategy also allows efficient dissection of compound regulatory regions previously assessed in transgenic mice. Remarkable overlap in expression patterns driven by sets of agCNEs indicates that PAX6 resides in a landscape of multiple tissue-specific regulatory archipelagos. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
231. Heterozygous Loss-of-Function Mutations in YAP1 Cause Both Isolated and Syndromic Optic Fissure Closure Defects.
- Author
-
Williamson, Kathleen?A., Rainger, Joe, Floyd, James?A.B., Ansari, Morad, Meynert, Alison, Aldridge, Kishan?V., Rainger, Jacqueline?K., Anderson, Carl?A., Moore, Anthony?T., Hurles, Matthew?E., Clarke, Angus, van?Heyningen, Veronica, Verloes, Alain, Taylor, Martin?S., Wilkie, Andrew?O.M., and FitzPatrick, David?R.
- Subjects
- *
CEREBRAL sulci , *ETIOLOGY of diseases , *NONSENSE mutation , *REVERSE transcriptase polymerase chain reaction , *LABORATORY mice , *NUCLEOTIDE sequence , *PHENOTYPES - Abstract
Exome sequence analysis of affected individuals from two families with autosomal-dominant inheritance of coloboma identified two different cosegregating heterozygous nonsense mutations (c.370C>T [p.Arg124∗] and c. 1066G>T [p.Glu356∗]) in YAP1. The phenotypes of the affected families differed in that one included no extraocular features and the other manifested with highly variable multisystem involvement, including hearing loss, intellectual disability, hematuria, and orofacial clefting. A combined LOD score of 4.2 was obtained for the association between YAP1 loss-of-function mutations and the phenotype in these families. YAP1 encodes an effector of the HIPPO-pathway-induced growth response, and whole-mount in situ hybridization in mouse embryos has shown that Yap1 is strongly expressed in the eye, brain, and fusing facial processes. RT-PCR showed that an alternative transcription start site (TSS) in intron 1 of YAP1 and Yap1 is widely used in human and mouse development, respectively. Transcripts from the alternative TSS are predicted to initiate at codon Met179 relative to the canonical transcript (RefSeq NM_001130145). In these alternative transcripts, the c.370C>T mutation in family 1305 is within the 5′ UTR and cannot result in nonsense-mediated decay (NMD). The c. 1066G>T mutation in family 132 should result in NMD in transcripts from either TSS. Amelioration of the phenotype by the alternative transcripts provides a plausible explanation for the phenotypic differences between the families. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
232. Pleiotropic Effects of Sox2 during the Development of the Zebrafish Epithalamus.
- Author
-
Pavlou, Sofia, Astell, Katy, Kasioulis, Ioannis, Gakovic, Milica, Baldock, Richard, van Heyningen, Veronica, and Coutinho, Pedro
- Subjects
- *
FISH growth , *THALAMUS physiology , *ZEBRA danio , *DIENCEPHALON , *GENETIC transcription , *GENETIC regulation , *DEVELOPMENTAL neurobiology , *PHOTORECEPTORS - Abstract
The zebrafish epithalamus is part of the diencephalon and encompasses three major components: the pineal, the parapineal and the habenular nuclei. Using sox2 knockdown, we show here that this key transcriptional regulator has pleiotropic effects during the development of these structures. Sox2 negatively regulates pineal neurogenesis. Also, Sox2 is identified as the unknown factor responsible for pineal photoreceptor prepatterning and performs this function independently of the BMP signaling. The correct levels of sox2 are critical for the functionally important asymmetrical positioning of the parapineal organ and for the migration of parapineal cells as a coherent structure. Deviations from this strict control result in defects associated with abnormal habenular laterality, which we have documented and quantified in sox2 morphants. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
233. Disruption of Autoregulatory Feedback by a Mutation in a Remote, Ultraconserved PAX6 Enhancer Causes Aniridia.
- Author
-
Bhatia, Shipra, Bengani, Hemant, Fish, Margaret, Brown, Alison, Divizia, Maria?Teresa, de?Marco, Riccardo, Damante, Guiseppe, Grainger, Robert, van?Heyningen, Veronica, and Kleinjan, Dirk?A.
- Subjects
- *
GENETIC mutation , *ANIRIDIA , *GENETIC regulation , *CHROMOSOME abnormalities , *POINT mutation (Biology) , *GENE expression - Abstract
The strictly regulated expression of most pleiotropic developmental control genes is critically dependent on the activity of long-range cis-regulatory elements. This was revealed by the identification of individuals with a genetic condition lacking coding-region mutations in the gene commonly associated with the disease but having a variety of nearby chromosomal abnormalities, collectively described as cis-ruption disease cases. The congenital eye malformation aniridia is caused by haploinsufficiency of the developmental regulator PAX6. We discovered a de novo point mutation in an ultraconserved cis-element located 150 kb downstream from PAX6 in an affected individual with intact coding region and chromosomal locus. The element SIMO acts as a strong enhancer in developing ocular structures. The mutation disrupts an autoregulatory PAX6 binding site, causing loss of enhancer activity, resulting in defective maintenance of PAX6 expression. These findings reveal a distinct regulatory mechanism for genetic disease by disruption of an autoregulatory feedback loop critical for maintenance of gene expression through development. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
234. Sequencing of Pax6 Loci from the Elephant Shark Reveals a Family of Pax6 Genes in Vertebrate Genomes, Forged by Ancient Duplications and Divergences.
- Author
-
Ravi, Vydianathan, Bhatia, Shipra, Gautier, Philippe, Loosli, Felix, Tay, Boon-Hui, Tay, Alice, Murdoch, Emma, Coutinho, Pedro, van Heyningen, Veronica, Brenner, Sydney, Venkatesh, Byrappa, and Kleinjan, Dirk A.
- Abstract
Pax6 is a developmental control gene essential for eye development throughout the animal kingdom. In addition, Pax6 plays key roles in other parts of the CNS, olfactory system, and pancreas. In mammals a single Pax6 gene encoding multiple isoforms delivers these pleiotropic functions. Here we provide evidence that the genomes of many other vertebrate species contain multiple Pax6 loci. We sequenced Pax6-containing BACs from the cartilaginous elephant shark (Callorhinchus milii) and found two distinct Pax6 loci. Pax6.1 is highly similar to mammalian Pax6, while Pax6.2 encodes a paired-less Pax6. Using synteny relationships, we identify homologs of this novel paired-less Pax6.2 gene in lizard and in frog, as well as in zebrafish and in other teleosts. In zebrafish two full-length Pax6 duplicates were known previously, originating from the fish-specific genome duplication (FSGD) and expressed in divergent patterns due to paralog-specific loss of cis-elements. We show that teleosts other than zebrafish also maintain duplicate full-length Pax6 loci, but differences in gene and regulatory domain structure suggest that these Pax6 paralogs originate from a more ancient duplication event and are hence renamed as Pax6.3. Sequence comparisons between mammalian and elephant shark Pax6.1 loci highlight the presence of short- and long-range conserved noncoding elements (CNEs). Functional analysis demonstrates the ancient role of long-range enhancers for Pax6 transcription. We show that the paired-less Pax6.2 ortholog in zebrafish is expressed specifically in the developing retina. Transgenic analysis of elephant shark and zebrafish Pax6.2 CNEs with homology to the mouse NRE/Pa internal promoter revealed highly specific retinal expression. Finally, morpholino depletion of zebrafish Pax6.2 resulted in a ''small eye'' phenotype, supporting a role in retinal development. In summary, our study reveals that the pleiotropic functions of Pax6 in vertebrates are served by a divergent family of Pax6 genes, forged by ancient duplication events and by independent, lineage-specific gene losses. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
235. The Developmental Regulator Pax6 Is Essential for Maintenance of Islet Cell Function in the Adult Mouse Pancreas.
- Author
-
Hart, Alan W., Mella, Sebastien, Mendrychowski, Jacek, van Heyningen, Veronica, and Kleinjan, Dirk A.
- Subjects
- *
TRANSCRIPTION factors , *ISLANDS of Langerhans , *PANCREAS , *GLUCOSE , *SOMATOSTATIN , *PEPTIDE hormones , *RODENTS - Abstract
The transcription factor Pax6 is a developmental regulator with a crucial role in development of the eye, brain, and olfactory system. Pax6 is also required for correct development of the endocrine pancreas and specification of hormone producing endocrine cell types. Glucagon-producing cells are almost completely lost in Pax6-null embryos, and insulin-expressing beta and somatostatin-expressing delta cells are reduced. While the developmental role of Pax6 is well-established, investigation of a further role for Pax6 in the maintenance of adult pancreatic function is normally precluded due to neonatal lethality of Pax6-null mice. Here a tamoxifen-inducible ubiquitous Cre transgene was used to inactivate Pax6 at 6 months of age in a conditional mouse model to assess the effect of losing Pax6 function in adulthood. The effect on glucose homeostasis and the expression of key islet cell markers was measured. Homozygous Pax6 deletion mice, but not controls, presented with all the symptoms of classical diabetes leading to severe weight loss requiring termination of the experiment five weeks after first tamoxifen administration. Immunohistochemical analysis of the pancreata revealed almost complete loss of Pax6 and much reduced expression of insulin, glucagon, and somatostatin. Several other markers of islet cell function were also affected. Notably, strong upregulation in the number of ghrelin-expressing endocrine cells was observed. These findings demonstrate that Pax6 is essential for adult maintenance of glucose homeostasis and function of the endocrine pancreas. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
236. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3.
- Author
-
Ragvin, Anja, Moro, Enrico, Fredman, David, Navratilova, Pavla, Drivenes, Øyvind, Engström, Pär G., AIonso, M. Eva, de Ia Calle Mustienes, Elisa, José Luis Gômez Skarmeta, Tavares, Maria J., Casares, Fernando, Manzanares, Miguel, van Heyningen, Veronica, MoIven, Anders, NjøIstad, Pål R., Argenton, Francesco, Lenhard, Boris, and Becker, Thomas S.
- Subjects
- *
GENETIC regulation , *GENOMICS , *TYPE 2 diabetes , *OBESITY , *LINKAGE disequilibrium , *TRANSCRIPTION factors , *TRANSGENIC mice , *ISLANDS of Langerhans - Abstract
Genome-wide association studies identified noncoding SNP5 associated with type 2 diabetes and obesity in linkage disequilibrium (LD) blocks encompassing HHEX-IDE and introns of CDKALI and FTO [Sladek R. et al. (200?) Nature 445:881-885; Steinthorsdottir V. et al.j(2007) Nat. Genet 39:770-775; Frayling TM, et al. (2007) Science [16:889-894]. We show that these LD blocks contain highly conserved noncoding elements and overlap with the genomic regulatory locks of the transcription factor genes HHEX, 50X4, and IRX3. We report that human highly conserved noncoding elements in ID wish the risk SNP5 drive expression in endoderm or pancreas in transgeijiic mice and zebrafish. Both HHEX and SOX4 have recently been implicated in pancreas development and the regulation of insulin secretion, but 1RX3 had no prior association with pancreatic function or development. Knockdown of its orthologue in zebrafish, irx3a, increased the number of pancreatic ghrelin-producing epsilon Jells and decreased the number of insulin-producing n-cells and glucagon-producing β-cells, thereby suggesting a direct link of pancreatic IRX3 function to both obesity and type 2 diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
237. The Level of the Transcription Factor Pax6 Is Essential for Controlling the Balance between Neural Stem Cell Self-Renewal and Neurogenesis.
- Author
-
Sansom, Stephen N., Griffiths, Dean S., Faedo, Andrea, Kleinjan, Dirk-Jan, Ruan, Youlin, Smith, James, Van Heyningen, Veronica, Rubenstein, John L., and Livesey, Frederick J.
- Subjects
- *
NEURAL stem cells , *DEVELOPMENTAL neurobiology , *CELL determination , *CENTRAL nervous system , *CEREBRAL cortex , *CELL proliferation - Abstract
Neural stem cell self-renewal, neurogenesis, and cell fate determination are processes that control the generation of specific classes of neurons at the correct place and time. The transcription factor Pax6 is essential for neural stem cell proliferation, multipotency, and neurogenesis in many regions of the central nervous system, including the cerebral cortex. We used Pax6 as an entry point to define the cellular networks controlling neural stem cell self-renewal and neurogenesis in stem cells of the developing mouse cerebral cortex. We identified the genomic binding locations of Pax6 in neocortical stem cells during normal development and ascertained the functional significance of genes that we found to be regulated by Pax6, finding that Pax6 positively and directly regulates cohorts of genes that promote neural stem cell self-renewal, basal progenitor cell genesis, and neurogenesis. Notably, we defined a core network regulating neocortical stem cell decision-making in which Pax6 interacts with three other regulators of neurogenesis, Neurog2, Ascl1, and Hes1. Analyses of the biological function of Pax6 in neural stem cells through phenotypic analyses of Pax6 gain- and loss-of-function mutant cortices demonstrated that the Pax6-regulated networks operating in neural stem cells are highly dosage sensitive. Increasing Pax6 levels drives the system towards neurogenesis and basal progenitor cell genesis by increasing expression of a cohort of basal progenitor cell determinants, including the key transcription factor Eomes/Tbr2, and thus towards neurogenesis at the expense of selfrenewal. Removing Pax6 reduces cortical stem cell self-renewal by decreasing expression of key cell cycle regulators, resulting in excess early neurogenesis. We find that the relative levels of Pax6, Hes1, and Neurog2 are key determinants of a dynamic network that controls whether neural stem cells self-renew, generate cortical neurons, or generate basal progenitor cells, a mechanism that has marked parallels with the transcriptional control of embryonic stem cell self-renewal. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
238. Subfunctionalization of Duplicated Zebrafish pax6 Genes by cis-Regulatory Divergence.
- Author
-
Kleinjan, Dirk A., Bancewicz, Ruth M., Gautier, Philippe, Dahm, Ralf, Schonthaler, Helia B., Damante, Giuseppe, Seawright1, Anne, Hever, Ann M., Yeyati, Patricia L., van Heyningen, Veronica, and Coutinho, Pedro
- Subjects
- *
GENETICS , *BIOLOGICAL divergence , *PHENOTYPES , *ZEBRA danio , *VERTEBRATES - Abstract
Gene duplication is a major driver of evolutionary divergence. In most vertebrates a single PAX6 gene encodes a transcription factor required for eye, brain, olfactory system, and pancreas development. In zebrafish, following a postulated whole-genome duplication event in an ancestral teleost, duplicates pax6a and pax6b jointly fulfill these roles. Mapping of the homozygously viable eye mutant sunrise identified a homeodomain missense change in pax6b, leading to loss of target binding. The mild phenotype emphasizes role-sharing between the co-orthologues. Meticulous mapping of isolated BACs identified perturbed synteny relationships around the duplicates. This highlights the functional conservation of pax6 downstream (3′) control sequences, which in most vertebrates reside within the introns of a ubiquitously expressed neighbour gene, ELP4, whose pax6a-linked exons have been lost in zebrafish. Reporter transgenic studies in both mouse and zebrafish, combined with analysis of vertebrate sequence conservation, reveal loss and retention of specific cis-regulatory elements, correlating strongly with the diverged expression of coorthologues, and providing clear evidence for evolution by subfunctionalization. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
239. Role of SOX2 Mutations in Human Hippocampal Malformations and Epilepsy.
- Author
-
Sisodiya, Sanjay M., Ragge, Nicola K., Cavalleri, Gianpiero L., Hever, Ann, Lorenz, Birgit, Schneider, Adele, Williamson, Kathleen A., Stevens, John M., Free, Samantha L., Thompson, Pamela J., van Heyningen, Veronica, and FitzPatrick, David R.
- Subjects
- *
EPILEPSY , *GENES , *HIPPOCAMPUS (Brain) , *EYE diseases , *TEMPORAL lobe , *FEBRILE seizures - Abstract
Purpose: Seizures are noted in a significant proportion of cases of de novo, heterozygous, loss-of-function mutations in SOX2, ascertained because of severe bilateral eye malformations. We wished to determine the underlying cerebral phenotype in SOX2 mutation and to test the candidacy of SOX2 as a gene contributing to human epilepsies. Methods: We examined high-resolution MRI scans in four patients with SOX2 mutations, two of whom had seizures. We determined the Sox2 expression pattern in developing murine brain. We searched for SOX2 mutation in 24 patients with typical hippocampal sclerosis and for common variations in SOX2 in 655 patients without eye disease but with epilepsy, including 91 patients with febrile seizures, 93 with hippocampal sclerosis, and 258 with temporal lobe epilepsy. Results: Striking hippocampal and parahippocampal malformations were seen in all cases, with a history of febrile seizures or epilepsy in two of four cases. The Sox2 expression pattern in developing mouse brain supports the pattern of malformations observed. Mutation screening in patients with epilepsy did not reveal any abnormalities in SOX2. No associations were found between any clinical epilepsy phenotype and common variation in SOX2. Conclusions: SOX2 haploinsufficiency causes mesial temporal malformation in humans, making SOX2 dysfunction a candidate mechanism for mesial temporal abnormalities associated with chronic epilepsy. However, although mutation of SOX2 in humans causes hippocampal malformation, SOX2 mutation or variation is unlikely to contribute commonly to mesial temporal lobe epilepsy or its structural (hippocampal sclerosis) or historic (febrile seizures) associations in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
240. Conserved elements in Pax6 intron 7 involved in (auto)regulation and alternative transcription
- Author
-
Kleinjan, Dirk A., Seawright, Anne, Childs, Andrew J., and van Heyningen, Veronica
- Subjects
- *
TRANSCRIPTION factors , *EYE , *CENTRAL nervous system , *EMBRYOS - Abstract
Pax6 is a transcription factor with an essential role in eye, central nervous system, and pancreas development. Its expression pattern is restricted to these specific domains within the developing embryo. Here four conserved elements are identified in Pax6 intron 7, showing a high level of sequence conservation between human, mouse, pufferfish, and zebrafish. Three of these are shown to act as cis-regulatory elements, directing expression of a reporter gene to distinct subsets of the Pax6 expression domain. CE1 regulates gene expression in late eye development, CE2 drives expression in the diencephalon and in the developing heart tube where Pax6 is not normally expressed, while CE3 directs expression in rhombencephalon. CE2 is shown to be autoregulated in the diencephalon, responding to absence of Pax6. We identify a highly conserved Pax6 recognition site and demonstrate its ability to bind Pax6 specifically. CE1 is embedded in a CpG island, and we identify a novel Pax6 transcript which initiates from this region. Functional analysis of evolutionary conserved sequences pinpoints novel cis-acting elements that govern the regulation of the complex spatio-temporal and quantitative expression of Pax6. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
241. Opening Up Spaces for Reflexivity? Scientists’ Discourses about Stem Cell Research and Public Engagement
- Author
-
Marks, Nicola J, van Heyningen, Veronica, and Parry, S
- Subjects
Medical sciences - Abstract
This thesis starts with what the House of Lords Third Report (2000) has identified as a “crisis of trust” between science and society. It explores ways of addressing this crisis by examining stem cell researchers’ discourses about their work and public engagement, and suggests ways of improving scientists’ engagement with publics. My journey from natural to social sciences started with an in-depth critical analysis of constructive (or critical) perspectives on public understanding of science (e.g. Irwin and Wynne). This highlighted the importance of investigating scientific institutions and scientists, and their embedded assumptions about publics, engagement and science. My research expands upon the limited empirical research on this topic and draws upon data from interviews and discussions with 54 stem cell researchers (of different levels of seniority and field of research, in Australia and the UK). Using informants’ discourse as a “topic” and a “resource” (Gilbert and Mulkay), the thesis explores in detail the strategic and socially contingent definitions and boundaries (Gieryn) in stem cell research (SCR). Analysis of the empirical material develops four main themes. Firstly, the language and conceptual fluidity of SCR is emphasised and shown to enable scientists to conduct “boundary-work” in a variety of ways. Secondly, discourses and performances of (un)certainty are examined to highlight a diversity of socially contingent identities SCR professionals can draw upon. This examination draws on MacKenzie’s “certainty trough” but also improves it by problematising the concept of “distance from knowledge production”. Thirdly, scientists’ expressions of trust and ambivalence are analysed as interactions with particular “expert systems” such as processes of informed consent, commercialisation or legislation in conditions of increased globalisation. By highlighting hermeneutic aspects of trust, this analysis is sharpened and shows that there are elements of “counter-modernity” as well as “reflexive modernisation” in SCR. It is argued that, to further explore the reflexive potential of stem cell professionals’ critiques of their work, these need to be further discussed in public. The forth and final theme focuses more specifically on engagement. Stem cell researchers’ accounts are shown to construct and perform publics, scientists and engagement – and thus “scientific citizenship” – in a variety of ways. This variety can be made sense of by reflecting on conceptions of expertise, democracy, and power. This enables the development of six “ideal-types” of engagement that can be used heuristically to study performances of citizenship. The thesis concludes by discussing its main contributions to knowledge. It highlights how social scientists can encourage greater “interpretative reflexivity” (Lynch) on the part of scientists; this can, in turn, lead to improved science-public relations.
- Published
- 2008
242. Discovery and assessment of conserved Pax6 target genes and enhancers.
- Author
-
Coutinho, Pedro, Pavlou, Sofia, Bhatia, Shipra, Chalmers, Kevin J., Kleinjan, Dirk A., and van Heyningen, Veronica
- Subjects
- *
ZEBRA danio , *GENETIC transcription , *BIOCHEMISTRY , *MARKOV processes , *RNA - Abstract
The characterization of transcriptional networks (TNs) is essential for understanding complex biological phenomena such as development, disease, and evolution. In this study, we have designed and implemented a procedure that combines in silico target screens with zebrafish and mouse validation, in order to identify cis-elements and genes directly regulated by Pax6. We chose Pax6 as the paradigm because of its crucial roles in organogenesis and human disease. We identified over 600 putative Pax6 binding sites and more than 200 predicted direct target genes, conserved in evolution from zebrafish to human and to mouse. This was accomplished using hidden Markov models (HMMs) generated from experimentally validated Pax6 binding sites. A small sample of genes, expressed in the neural lineage, was chosen from the predictions for RNA in situ validation using zebrafish and mouse models. Validation of DNA binding to some predicted cis-elements was also carried out using chromatin immunoprecipitation (ChIP) and zebrafish reporter transgenic studies. The results show that this combined procedure is a highly efficient tool to investigate the architecture of TNs and constitutes a useful complementary resource to ChIP and expression data sets because of its inherent spatiotemporal independence. We have identified several novel direct targets, including some putative disease genes, among them Foxp2; these will allow further dissection of Pax6 function in development and disease. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
243. Stochasticity in genetics and gene regulation.
- Author
-
van Heyningen V
- Subjects
- Cell Differentiation, Alternative Splicing, Brain, X Chromosome Inactivation, Transcription Factors
- Abstract
Development from fertilized egg to functioning multi-cellular organism requires precision. There is no precision, and often no survival, without plasticity. Plasticity is conferred partly by stochastic variation, present inherently in all biological systems. Gene expression levels fluctuate ubiquitously through transcription, alternative splicing, translation and turnover. Small differences in gene expression are exploited to trigger early differentiation, conferring distinct function on selected individual cells and setting in motion regulatory interactions. Non-selected cells then acquire new functions along the spatio-temporal developmental trajectory. The differentiation process has many stochastic components. Meiotic segregation, mitochondrial partitioning, X-inactivation and the dynamic DNA binding of transcription factor assemblies-all exhibit randomness. Non-random X-inactivation generally signals deleterious X-linked mutations. Correct neural wiring, such as retina to brain, arises through repeated confirmatory activity of connections made randomly. In immune system development, both B-cell antibody generation and the emergence of balanced T-cell categories begin through stochastic trial and error followed by functional selection. Aberrant selection processes lead to immune dysfunction. DNA sequence variants also arise through stochastic events: some involving environmental fluctuation (radiation or presence of pollutants), or genetic repair system malfunction. The phenotypic outcome of mutations is also fluid. Mutations may be advantageous in some circumstances, deleterious in others. This article is part of a discussion meeting issue 'Causes and consequences of stochastic processes in development and disease'.
- Published
- 2024
- Full Text
- View/download PDF
244. Short-read whole genome sequencing identifies causative variants in most individuals with previously unexplained aniridia.
- Author
-
Hall HN, Parry D, Halachev M, Williamson KA, Donnelly K, Campos Parada J, Bhatia S, Joseph J, Holden S, Prescott TE, Bitoun P, Kirk EP, Newbury-Ecob R, Lachlan K, Bernar J, van Heyningen V, FitzPatrick DR, and Meynert A
- Subjects
- Humans, PAX6 Transcription Factor genetics, Mutation genetics, Exons, Homeodomain Proteins genetics, Eye Proteins genetics, Pedigree, Aniridia genetics, Eye Abnormalities genetics
- Abstract
Background: Classic aniridia is a highly penetrant autosomal dominant disorder characterised by congenital absence of the iris, foveal hypoplasia, optic disc anomalies and progressive opacification of the cornea. >90% of cases of classic aniridia are caused by heterozygous, loss-of-function variants affecting the PAX6 locus., Methods: Short-read whole genome sequencing was performed on 51 (39 affected) individuals from 37 different families who had screened negative for mutations in the PAX6 coding region., Results: Likely causative mutations were identified in 22 out of 37 (59%) families. In 19 out of 22 families, the causative genomic changes have an interpretable deleterious impact on the PAX6 locus. Of these 19 families, 1 has a novel heterozygous PAX6 frameshift variant missed on previous screens, 4 have single nucleotide variants (SNVs) (one novel) affecting essential splice sites of PAX6 5' non-coding exons and 2 have deep intronic SNV (one novel) resulting in gain of a donor splice site. In 12 out of 19, the causative variants are large-scale structural variants; 5 have partial or whole gene deletions of PAX6 , 3 have deletions encompassing critical PAX6 cis -regulatory elements, 2 have balanced inversions with disruptive breakpoints within the PAX6 locus and 2 have complex rearrangements disrupting PAX6 . The remaining 3 of 22 families have deletions encompassing FOXC1 (a known cause of atypical aniridia). Seven of the causative variants occurred de novo and one cosegregated with familial aniridia. We were unable to establish inheritance status in the remaining probands. No plausibly causative SNVs were identified in PAX6 cis -regulatory elements., Conclusion: Whole genome sequencing proves to be an effective diagnostic test in most individuals with previously unexplained aniridia., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
245. A Journey Through Genetics to Biology.
- Author
-
van Heyningen V
- Subjects
- Animals, Humans, Genomics
- Abstract
Although my engagement with human genetics emerged gradually, and sometimes serendipitously, it has held me spellbound for decades. Without my teachers, students, postdocs, colleagues, and collaborators, I would not be writing this review of my scientific adventures. Early gene and disease mapping was a satisfying puzzle-solving exercise, but building biological insight was my main goal. The project trajectory was hugely influenced by the evolutionarily conserved nature of the implicated genes and by the pace of progress in genetic technologies. The rich detail of clinical observations, particularly in eye disease, makes humans an excellent model, especially when complemented by the use of multiple other animal species for experimental validation. The contributions of collaborators and rivals also influenced our approach. We are very fortunate to work in this era of unprecedented progress in genetics and genomics.
- Published
- 2022
- Full Text
- View/download PDF
246. Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA-protein interaction.
- Author
-
Williamson KA, Hall HN, Owen LJ, Livesey BJ, Hanson IM, Adams GGW, Bodek S, Calvas P, Castle B, Clarke M, Deng AT, Edery P, Fisher R, Gillessen-Kaesbach G, Heon E, Hurst J, Josifova D, Lorenz B, McKee S, Meire F, Moore AT, Parker M, Reiff CM, Self J, Tobias ES, Verheij JBGM, Willems M, Williams D, van Heyningen V, Marsh JA, and FitzPatrick DR
- Subjects
- Adolescent, Adult, Binding Sites genetics, Child, Child, Preschool, Cohort Studies, DNA-Binding Proteins genetics, Eye Abnormalities pathology, Female, Heterozygote, Humans, Infant, Male, Microphthalmos pathology, Mutation, Missense genetics, Pedigree, Young Adult, Eye Abnormalities genetics, Genetic Predisposition to Disease, Microphthalmos genetics, PAX6 Transcription Factor genetics
- Abstract
Purpose: Most classical aniridia is caused by PAX6 haploinsufficiency. PAX6 missense variants can be hypomorphic or mimic haploinsufficiency. We hypothesized that missense variants also cause previously undescribed disease by altering the affinity and/or specificity of PAX6 genomic interactions., Methods: We screened PAX6 in 372 individuals with bilateral microphthalmia, anophthalmia, or coloboma (MAC) from the Medical Research Council Human Genetics Unit eye malformation cohort (HGU
eye ) and reviewed data from the Deciphering Developmental Disorders study. We performed cluster analysis on PAX6-associated ocular phenotypes by variant type and molecular modeling of the structural impact of 86 different PAX6 causative missense variants., Results: Eight different PAX6 missense variants were identified in 17 individuals (15 families) with MAC, accounting for 4% (15/372) of our cohort. Seven altered the paired domain (p.[Arg26Gln]x1, p.[Gly36Val]x1, p.[Arg38Trp]x2, p.[Arg38Gln]x1, p.[Gly51Arg]x2, p.[Ser54Arg]x2, p.[Asn124Lys]x5) and one the homeodomain (p.[Asn260Tyr]x1). p.Ser54Arg and p.Asn124Lys were exclusively associated with severe bilateral microphthalmia. MAC-associated variants were predicted to alter but not ablate DNA interaction, consistent with the electrophoretic mobility shifts observed using mutant paired domains with well-characterized PAX6-binding sites. We found no strong evidence for novel PAX6-associated extraocular disease., Conclusion: Altering the affinity and specificity of PAX6-binding genome-wide provides a plausible mechanism for the worse-than-null effects of MAC-associated missense variants.- Published
- 2020
- Full Text
- View/download PDF
247. Genome sequencing-the dawn of a game-changing era.
- Author
-
van Heyningen V
- Subjects
- Animals, Blotting, Southern, Caenorhabditis elegans genetics, Chromosome Mapping methods, Genetic Predisposition to Disease, Genome, Genomics history, History, 20th Century, Humans, Sequence Analysis, DNA methods, Computational Biology methods, Genomics methods, Human Genome Project
- Abstract
The development of genome sequencing technologies has revolutionized the biological sciences in ways which could not have been imagined at the time. This article sets out to document the dawning of the age of genomics and to consider the impact of this revolution on biological investigation, our understanding of life, and the relationship between science and society.
- Published
- 2019
- Full Text
- View/download PDF
248. Professor Sue Povey (1942-2019). Former Editor-in-Chief of the Annals of Human Genetics, died January 11th 2019.
- Author
-
Swallow D and van Heyningen V
- Published
- 2019
- Full Text
- View/download PDF
249. Unique noncoding variants upstream of PRDM13 are associated with a spectrum of developmental retinal dystrophies including progressive bifocal chorioretinal atrophy.
- Author
-
Silva RS, Arno G, Cipriani V, Pontikos N, Defoort-Dhellemmes S, Kalhoro A, Carss KJ, Raymond FL, Dhaenens CM, Jensen H, Rosenberg T, van Heyningen V, Moore AT, Puech B, and Webster AR
- Subjects
- Adult, Computational Biology methods, Female, Genetic Association Studies methods, Genetic Loci, Haplotypes, Humans, Multigene Family, Pedigree, Whole Genome Sequencing, 5' Untranslated Regions, Corneal Dystrophies, Hereditary diagnosis, Corneal Dystrophies, Hereditary genetics, Genetic Predisposition to Disease, Histone-Lysine N-Methyltransferase genetics, Retinal Dystrophies diagnosis, Retinal Dystrophies genetics, Transcription Factors genetics
- Abstract
The autosomal dominant progressive bifocal chorioretinal atrophy (PBCRA) disease locus has been mapped to chromosome 6q14-16.2 that overlaps the North Carolina macular dystrophy (NCMD) locus MCDR1. NCMD is a nonprogressive developmental macular dystrophy, in which variants upstream of PRDM13 have been implicated. Whole genome sequencing was performed to interrogate structural variants (SVs) and single nucleotide variants (SNVs) in eight individuals, six affected individuals from two families with PBCRA, and two individuals from an additional family with a related developmental macular dystrophy. A SNV (chr6:100,046,804T>C), located 7.8 kb upstream of the PRDM13 gene, was shared by all PBCRA-affected individuals in the disease locus. Haplotype analysis suggested that the variant arose independently in the two families. The two affected individuals from Family 3 were screened for rare variants in the PBCRA and NCMD loci. This revealed a de novo variant in the proband, 21 bp from the first SNV (chr6:100,046,783A>C). This study expands the noncoding variant spectrum upstream of PRDM13 and suggests altered spatio-temporal expression of PRDM13 as a candidate disease mechanism in the phenotypically distinct but related conditions, NCMD and PBCRA., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
250. Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus.
- Author
-
Cipriani V, Silva RS, Arno G, Pontikos N, Kalhoro A, Valeina S, Inashkina I, Audere M, Rutka K, Puech B, Michaelides M, van Heyningen V, Lace B, Webster AR, and Moore AT
- Subjects
- ADAMTS Proteins metabolism, Adult, Base Sequence, Chromosome Duplication, Chromosomes, Human, Pair 5 chemistry, Chromosomes, Human, Pair 6 chemistry, Corneal Dystrophies, Hereditary diagnostic imaging, Corneal Dystrophies, Hereditary pathology, Eye Proteins metabolism, Family, Female, Fetus, Gene Expression, Haplotypes, Homeodomain Proteins metabolism, Humans, Male, Retina metabolism, Retina pathology, Sequence Analysis, DNA, Tomography, Optical Coherence, Transcription Factors metabolism, ADAMTS Proteins genetics, Corneal Dystrophies, Hereditary genetics, Eye Proteins genetics, Genetic Loci, Homeodomain Proteins genetics, Transcription Factors genetics
- Abstract
Autosomal dominant North Carolina macular dystrophy (NCMD) is believed to represent a failure of macular development. The disorder has been linked to two loci, MCDR1 (chromosome 6q16) and MCDR3 (chromosome 5p15-p13). Recently, non-coding variants upstream of PRDM13 (MCDR1) and a duplication including IRX1 (MCDR3) have been identified. However, the underlying disease-causing mechanism remains uncertain. Through a combination of sequencing studies on eighteen NCMD families, we report two novel overlapping duplications at the MCDR3 locus, in a gene desert downstream of IRX1 and upstream of ADAMTS16. One duplication of 43 kb was identified in nine families (with evidence for a shared ancestral haplotype), and another one of 45 kb was found in a single family. Three families carry the previously reported V2 variant (MCDR1), while five remain unsolved. The MCDR3 locus is thus refined to a shared region of 39 kb that contains DNAse hypersensitive sites active at a restricted time window during retinal development. Publicly available data confirmed expression of IRX1 and ADAMTS16 in human fetal retina, with IRX1 preferentially expressed in fetal macula. These findings represent a major advance in our understanding of the molecular genetics of NCMD and provide insights into the genetic pathways involved in human macular development.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.